Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: Impact on the course of the disease and health outcomes

Drugs and Aging

Volumn 31, Issue 7, 2014, Pages 483-492

  Yohannes, A M ^a   Alexopoulos, G S ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DYSPNEA; ELDERLY CARE; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; AGED; MEDICATION COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSION; HUMANS; MEDICATION ADHERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84903794094     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0186-0     Document Type: Review

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. www.goldcopd.org. Date last updated: Feb 2013. Accessed 13 Dec 2013.
2. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-86.
3. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in patients with chronic obstructive pulmonary disease. Rev Clin Gerontol. 2000;10(2):193-202. (Pubitemid 30598979)
4. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with disabling pulmonary disease: prevalence and validation of the BASDEC Screening Questionnaire. Int J Geriatr Psychiatry. 2000;15(12):1090-6. (Pubitemid 32093984)
5. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA. ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(Suppl 4):43S-56S.
6. NICE guideline. Depression in adults: the treatment and management of depression in adults. 2009. www.nice.org.uk/CG090. Accessed 13 Dec 2013.
7. Yohannes AM, Hann M, Sibbald B. The management of depressive symptoms in patients with COPD: a postal survey of general practitioners. Prim Health Care Res Dev. 2011;12(3):237-44.
8. Yohannes AM, Connolly MJ. Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med. 2011;5(6):727-9.
9. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209-21.
10. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766-77.
11. Tsai TY, Livneh H, Lu MC, Tsai PY, Chen PC, Sung FC. Increased risk and related factors of depression among patients with COPD: a population based cohort study. BMC Public Health. 2013;19(13):976. doi:10.1186/1471-2458-13-976.
12. Yohannes AM, Roomi J, Baldwin RC, Connolly MJ. Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing. 1998;27(2):155-60. (Pubitemid 28226954)
13. Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2):176-83.
14. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131(5):1557-66. (Pubitemid 46762366)
15. Nunes SO, Vargas HO, Brum J, Prado E, Vargas MM, de Castro MR, Dodd S, Berk M. A comparison of inflammatory markers in depressed and non-depressed smokers. Nicotine Tob Res. 2012;14(5):540-6.
16. Lu Y, Feng L, Feng L, Nyunt MS, Yap KB, Ng TP. Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir Res. 2013;14:53.
17. Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009;71(6):667-74.
18. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60-7. (Pubitemid 46072408)
19. Lou P, Chen P, Zhang P, Xu J, Wang Y, Chen N, Zhang L, Wu H, Zhao J. Effects of smoking, depression and anxiety on mortality in COPD patients: a prospective study. Respir Care. 2014;59(1):54-61.
20. Lu Y, Nyunt SZ, Gwee X, Feng L, Feng L, Kua EH, Kumar R, Ng TP. Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well-being and quality of life in a population-based study. BMJ Open. 2012;2:e001674.
21. Qian J, Simoni-Wastila L, Langenberg P, Rattinger GB, Zuckerman IH, Lehmann S, Terrin M. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2013;61(5):754-61.
22. Pirraglia PA, Charbonneau A, Kader B, Berlowitz DR. Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans. Prim Care Companion J Clin Psychiatry. 2006;8(2):71-6. (Pubitemid 44371585)
23. Nelson JC, Delucchi KL, Schneider LS. Moderators of outcome in late life depression: a patient level meta-analysis. Am J Psychiatry. 2013;170(6):651-9.
24. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Sharf SM, Gorman JM, et al. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry. 1995;152(10):1531.
25. Smoller JW, Pollack MH, Systrom D, Kardin RL. Sertraline effects on dyspnoea in patients with obstructive airways disease. Psychosomatics. 1998;39(1):24-9. (Pubitemid 28152594)
26. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12(8):817-24. (Pubitemid 27390092)
27. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16(5):451-4. (Pubitemid 32492377)
28. Lacasse Y, Beaudoin L, Rousseau L, Maltias F. Randomised trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61(3):140-7. (Pubitemid 40124039)
29. Eiser N, Harte R, Karvounis S, Phillips C, Isaac MT. Effect of treating depression on quality of life and exercise tolerance in severe COPD. COPD. 2005;2(2):233-41. (Pubitemid 40993298)
30. Gordon GH, Michiels TM, Mahutte CK, Light RW. Effect of despiramine on control of ventilation and depression scores in patients with chronic obstructive pulmonary disease. Psychiatry Res. 1985;15(1):25-32. (Pubitemid 15076504)
31. Light RW, Merrill EJ, Despairs J, Gordon GH, Mutalipassi LR. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med. 1986;146(7):1377-80. (Pubitemid 16075756)
32. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, van Tunien C. Improvement in mood physical symptoms, and function with nortiptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33(2):190-201.
33. Strom K, Boman G, Pehrsson K, Alton M, Singer J, Rydstrom PO, et al. Effect of protriptyline, 10 mg daily, on chronic hypoxemia in chronic obstructive pulmonary disease. Eur Respir J. 1995;8(3):425-9.
34. Alexopoulos GS, Raue PJ, Sirey JA, Arean PA. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int J Geriatr Psychiatry. 2008;23(5):447-53. (Pubitemid 351722102)
35. Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care in older adults with COPD. Int J Geriatr Psychiatry. 2007;22(3):154-9.
36. Yohannes AM. Management of anxiety and depression in patients with COPD. Expert Rev Respir Med. 2008;2(3):337-47. (Pubitemid 351959393)
37. Kiosses DN, Klimstra S, Murphy C, Alexopoulos GS. Executive dysfunction and disability in elderly patients with major depression. Am J Geriatr Psychiatry. 2001;9(3):269-74. (Pubitemid 32642978)
38. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Feder M, Einhorn A, Rosendahl E. Recovery in geriatric depression. Arch Gen Psychiatry. 1996;53(4):305-12. (Pubitemid 26115303)
39. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J. Executive dysfunction and longterm outcome of geriatric depression. Arch Gen Psychiatry. 2000;57(3):285-90. (Pubitemid 30140438)
40. Alexopoulos GS, Kiosses DN, Sirey JA, Kanellopoulos D, Novitch RS, Ghosh S, Seirup JK, Raue PJ. Personalised intervention for people with depression and severe COPD. Br J Psychiatry. 2013;202(3):235-6.
41. First MB, Spitzer L, Robert L, Gibbon M, Williams JBW. Structural clinical interview for DSM-IV-TR axis I. Disorders Research Version, Patient edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institute, 2002.
42. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(2):56-62.
43. Alexopoulos GS, Kiosses DN, Sirey JA, Kanellopoulos D, Seirup JK, Novitch RS, Ghosh S, Banerjee S, Raue PJ. Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD. Am J Geriatr Psychiatry. 2013. doi:10.1016/j.jagp.2013.05.006. [Epub ahead of print].
44. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy for depression. New York: Guildford Press; 1979.
45. Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104(7):986-94.
46. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008;38(3):385-96. (Pubitemid 351311679)
47. Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006;14(5):466-75.
48. Shultz E, Malone DA. A practical approach to prescribing anti-depressants. Clevl Clin J Med. 2013;80(10):625-31.